Find trials
Search tips

A Study to Evaluate Hemorrhage and Thrombosis in Hematology Malignancies

Overview

About this study

The purpose of this study is to determine:  the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in hospitalized malignant hematology patients, based on anticoagulant use and presence of thrombocytopenia, and recurrent or progressive venous thromboembolism in the 3 months following deep vein thrombosis diagnosis in hospitalized malignant hematology patients, based on anticoagulant use and presence of thrombocytopenia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years old.
  • Admitted to the Mayo Clinic Arizona Hematology A and B Service for initiation of:
    • new (or next line) chemotherapy;
    • autologous stem cell transplant; or
    • allogeneic stem cell transplant for a hematologic malignancy.
  • Consented patients with acute leukemia, Non Hodgkin and Hodgkin lymphoma, myeloproliferative neoplasm, multiple myeloma.

Exclusion Criteria:

  • Solid tumor malignancy patients.
  • Age < 18 years old.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Leslie Padrnos, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20507930

Mayo Clinic Footer